Cipher Pharmaceuticals (TSX:CPH) Current Deferred Revenue : C$16.71 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cipher Pharmaceuticals's current deferred revenue for the quarter that ended in Mar. 2025 was C$16.71 Mil.

Cipher Pharmaceuticals Current Deferred Revenue Historical Data

The historical data trend for Cipher Pharmaceuticals's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Current Deferred Revenue Chart

Cipher Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Revenue

Get a 7-Day Free Trial

0.39

0.58

0.35

0.75

18.96

Cipher Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Deferred Revenue	Get a 7-Day Free Trial															0.67	0.70	11.35	18.96	16.71

Cipher Pharmaceuticals Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipher Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

CPHRF:USA PHE:Germany PHE:Germany

Address

5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9

Website

https://www.cipherpharma.com

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Executives

Harold Morton Wolkin	Director
Christian Godin	Director
Bryan Jacobs	Senior Officer
Scott Langille	Senior Officer
Nadine Jutlah	Senior Officer
Arthur Marie Joseph Ghislain Deboeck	Director
Mark Beaudet	Director

Cipher Pharmaceuticals Headlines

No Headlines